References
- GersonSLMGMT: its role in cancer aetiology and cancer therapeuticsNat Rev Cancer20044429630715057289
- WibleyJEPeggAEMoodyPCCrystal structure of the human O(6)-alkylguanine-DNA alkyltransferaseNucleic Acids Res200028239340110606635
- LiuLAllayEDumencoLLGersonSLRapid repair of O6-methylgua-nine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomasCancer Res19945417464846528062258
- ZhouZQManguinoDKewittKSpontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6-methylguanine-DNA methyltransferaseProc Natl Acad Sci U S A20019822125661257111606727
- KawateHSakumiKTsuzukiTSeparation of killing and tumori-genic effects of an alkylating agent in mice defective in two of the DNA repair genesProc Natl Acad Sci U S A1998959511651209560238
- NakamuraMWatanabeTYonekawaYKleihuesPOhgakiHPromoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor geneCarcinogenesis200122101715171911577014
- EstellerMToyotaMSanchez-CespedesMInactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesisCancer Res20006092368237110811111
- BrentTPHoughtonPJHoughtonJAO6-Alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosoureaProc Natl Acad Sci U S A1985829298529893857628
- ScholdSCBrentTPvon HofeEO6-alkylguanine-DNA alk-yltransferase and sensitivity to procarbazine in human brain-tumor xenograftsJ Neurosurg19897045735772926498
- EstellerMHamiltonSRBurgerPCBaylinSBHermanJGInactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasiaCancer Res199959479379710029064
- EstellerMGarcia-FoncillasJAndionEInactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agentsN Engl J Med2000343191350135411070098
- HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
- UnoMOba-ShinjoSMCamargoAACorrelation of MGMT promoter methylation status with gene and protein expression levels in glioblastomaClinics201166101747175522012047
- HsuCYLinSCHoHLExclusion of histiocytes/endothelial cells and using endothelial cells as internal reference are crucial for interpretation of MGMT immunohistochemistry in glioblastomaAm J Surg Pathol201337226427123282970
- McDonaldKLRapkinsRWOlivierJThe T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patientsEur J Cancer201349236036822975219
- HsuCYHoHLLinSCHoTDHoDMThe MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastomaPLoS One20171210e018643029036186
- Kuroiwa-TrzmielinaJWangFRapkinsRWSNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal CancerClin Cancer Res201622246266627727267851
- KhuranaEFuYChakravartyDDemichelisFRubinMAGersteinMRole of non-coding sequence variants in cancerNat Rev Genet20161729310826781813
- OldridgeDAWoodACWeichert-LeaheyNGenetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphismNature2015528758241842126560027
- PomerantzMMAhmadiyehNJiaLThe 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancerNat Genet200941888288419561607
- FlicekPAmodeMRBarrellDEnsembl 2014Nucleic Acids Res201442Database issueD749D75524316576
- ViselAMinovitskySDubchakIPennacchioLAVISTA Enhancer Browser – a database of tissue-specific human enhancersNucleic Acids Res200735Database issueD88D9217130149
- PatenBHerreroJBealKFitzgeraldSBirneyEEnredoBEEnredo and Pecan: genome-wide mammalian consistency-based multiple alignment with paralogsGenome Res200818111814182818849524
- 1000 Genomes Project ConsortiumAutonABrooksLDDurbinRMA global reference for human genetic variationNature20155267571687426432245
- HuangLDaiLXuWZhangSYanDShiXIdentification of expression quantitative trait loci of MTOR associated with the progression of gliomaOncol Lett201815166567129387238
- HuangLXuWYanDDaiLShiXIdentification of expression quantitative trait loci of RPTOR for susceptibility to gliomaTumour Biol20163722305231126361958
- WacholderSChanockSGarcia-ClosasMEl GhormliLRothmanNAssessing the probability that a positive report is false: an approach for molecular epidemiology studiesJ Natl Cancer Inst200496643444215026468
- ChenRSmith-CohnMCohenALColmanHGlioma Subclassifications and Their Clinical SignificanceNeurotherapeutics201714228429728281173
- LiuYSheteSHoskingFRobertsonLHoulstonRBondyMGenetic advances in glioma: susceptibility genes and networksCurr Opin Genet Dev201020323924420211558
- ZawlikIVaccarellaSKitaDMittelbronnMFranceschiSOhgakiHPromoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based studyNeuroepidemiology2009321212918997474
- FranceschiETosoniAMinichilloSThe Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerWorld Neurosurg2018112e342e34729337169